|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Nov 30, 2020
|
FY2019
12 months to Nov 30, 2019
|
FY2018
12 months to Nov 30, 2018
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Noncash rental revenue including straight-line rents | |||||
| Gain on sales of real estate assets | |||||
| Amortization of terminated swap agreements and related income tax benefit | |||||
| Stock-based compensation expense | |||||
| Amortization of debt issuance costs | |||||
| Losses on early extinguishment of debt | |||||
| Amortization of terminated swap agreement | |||||
| Deferred income taxes | |||||
| Gain on sales of equipment | |||||
| Noncash impairment charge | |||||
| Change in fair value of financial instruments | |||||
| Changes in assets and liabilities: | |||||
| Other assets | |||||
| Accounts payable and accrued liabilities | |||||
| Deferred revenue | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Acquisitions of land and buildings | |||||
| Additions to real estate assets | |||||
| Proceeds from sales of real estate assets, net of expenses | |||||
| Proceeds from sales of real estate assets deposited in escrow | |||||
| Deposits on building and land acquisitions | |||||
| Deferred leasing costs and other | |||||
| Changes in short-term investments, net | |||||
| Proceeds from sale of equipment, net of expenses | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Principal payments on mortgage loans and construction loan | |||||
| Proceeds from delayed draw term loan and construction loan | |||||
| Dividends paid to stockholders | |||||
| Payment of debt issuance costs | |||||
| Proceeds from (payment for) termination of interest rate swap agreements | |||||
| Proceeds from exercise of stock options | |||||
| Payment for termination of interest rate swap agreement | |||||
| Net repayment on revolving lines of credit | |||||
| Proceeds from sale of warrants | |||||
| Proceeds from sale of common stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
Loading...